News

Crane (NYSE: CR) is a high-flying stock, having gained 58% since the IPO spin-off and keeping most of it. A recent downshift in analyst sentiment driven by valuation capped gains in January

From a technical standpoint, identifying a mid-cap stock that has performed as remarkably and consistently over one year as AppLovin (NYSE: APP) might be difficult.

Impressively, over the

As the U.S. Energy Information Agency forecasts natural gas prices to rise in 2024 and 2025, the $7.4 billion all-stock merger of Chesapeake Energy Corp. (NASDAQ: CHK) and Southwestern Energy Co.

Colgate-Palmolive (NYSE: CL) shares are trending higher within a range and have new highs in sight. The Q4 results, guidance and analysts' sentiment suggest it will set a new multi-year high soon

Every once in a while, stocks get too expensive or too cheap. As the market is a rough estimate of how the underlying United States economy is doing, any of the two extremes could signal that the

The markets may have just ended their super cycle for the past four years (2020-2024), sponsored by low-interest rate environments pushed by the FED to counteract the effects of the COVID-19

Shares of Snowflake Inc. (NYSE: SNOW), a cloud-based data storage, computing, and analytics company, have been impressive lately, with its stock rising almost 50% over the previous three months. 

Dividend Kings are attractive for income investors because of the reliable payments and insulation from market downturns. 

These buy-and-hold names are also tightly held, significantly affecting

Shares of Logitech International S.A. (NASDAQ: LOGI) fell sharply despite a solid earnings report and improved guidance. The move took share prices to a two-month low, setting up an attractive

Proctor & Gamble’s (NYSE: PG) stock price entered consolidation following the  COVID-19 bubble, but its uptrend is intact, and a trend-following signal is in play. Because the stock has sustained

Gene therapy will get its share of the spotlight in the medical sector in 2024. The FDA approval for Casgevy, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) and CRISPR Therapeutics AG (NASDAQ: CRSP)

Johnson & Johnson (NYSE: JNJ) had a solid quarter in Q4 despite the impacts of the Kenvue spin-off and the deleveraging of COVID-19 sales. However, little has emerged to catalyze the bulls

The rally in the spot price of uranium that began in 2023 is heating up in the first month of 2024. On January 15, the spot price of uranium broke the $103 level, a 16-year high. For uranium

2023 was a year to forget for the personal care industry. With traders clamoring for growth-oriented technology and media shares, the defensive group became an afterthought and woefully

You are about to witness a pivoting moment in the stock market, driven by similar changes in the underlying economy today. People tend to fall into a sort of continuation fallacy, where what has

Applied Digital Co. (NASDAQ: APLD) shares experienced a 4X surge in 2023, riding the artificial intelligence (AI) trend as a provider of next-generation AI data centers. Its data centers were

Shares of Birkenstock Holdings plc (NYSE: BIRK) made a decent recovery after falling more than 10% from its closing price of $50 on January 17, 2024. The reason for the stock's decline was the

The price action in SLB (NYSE: SLB) entered a correction last fall, but it has ended. Within a sustained uptrend, the correction has drilled to critical levels and rebounded after the Q4 earnings

In the early days of 2024, the SPDR S&P 500 ETF Trust (NYSE: SPY) is soaring near its all-time high, primarily driven by the impressive rally in the technology sector. Over the past month, it has